Oct 01, 08
|
| NEW STORY |
| 09:59 ET |
Samaritan Partners 'Forgetful' Rat Model to Taconic to Commercialize
|
 |
May 11, 05
|
| 08:45 ET |
Samaritan's Lead Oral Entry Inhibitor HIV Drug SP01A Initiates PII HIV Monotherapy Trial
|
|
Sep 16, 04
|
| 09:30 ET |
Samaritan In-Licenses New Alzheimer's Drug From Georgetown University for Further Development
|
|
Feb 03, 04
|
| 22:23 ET |
Samaritan CEO Discusses Innovative Drugs and Technologies for Alzheimer's on Radio
|
|
Jul 02, 03
|
| 03:12 ET |
Samaritan Positioned As 'Force' in the Treatment of Alzheimer's by CEO Greeson at Annual Meeting of Shareholders
|
|
Jun 23, 03
|
| 08:07 ET |
Samaritan Showcases Brand New Drug Candidates for Alzheimer's and AIDS Related Dementia to Attract Partners at BIO 2003
|
|
May 16, 03
|
| 05:00 ET |
Erasto Saldi, MD Appointed to Samaritan's Board of Directors
|
|
Apr 08, 03
|
| 10:01 ET |
Samaritan Expands Georgetown University Collaboration Strengthening and Enhancing Technology Pipeline
|
|
Apr 03, 03
|
| 05:00 ET |
Samaritan Hopes to Expedite Time-to-Market With FDA-Preferred, Reviewer- Friendly, Electronic Regulatory Submission of Positive HIV Phase II Data
|
|
Mar 31, 03
|
| 05:00 ET |
Samaritan Alzheimer's Technology Highlighted in BioPeople Magazine
|
|
Mar 16, 03
|
| 22:49 ET |
Samaritan Emphatically Denies 'Fictitious Allegations'
|
|
Mar 07, 03
|
| 05:00 ET |
Samaritan's Phase II (Proof of Concept) Trial Shows Statistically Significant Positive Results With HIV Drug
|
|
Feb 21, 03
|
| 14:48 ET |
Samaritan to Host Annual Meeting of Shareholders
|
|
|